HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M K Brenner Selected Research

Interleukin-12 (IL 12)

10/2007IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer.
1/2003Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M K Brenner Research Topics

Disease

22Neoplasms (Cancer)
06/2013 - 12/2000
4Lymphoma (Lymphomas)
06/2010 - 02/2000
4Neuroblastoma
01/2009 - 07/2000
3Leukemia
06/2010 - 08/2001
3Hodgkin Disease (Hodgkin's Disease)
04/2010 - 09/2001
2Infections
02/2014 - 11/2005
2Prostatic Neoplasms (Prostate Cancer)
06/2013 - 10/2007
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2010 - 04/2001
2Encephalitis (Encephalitis, Rasmussen)
09/2007 - 06/2007
2Graft vs Host Disease (Graft-Versus-Host Disease)
06/2007 - 03/2006
2Virus Diseases (Viral Diseases)
06/2007 - 01/2005
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2006 - 08/2001
1Febrile Neutropenia
02/2014
1Multiple Myeloma
02/2014
1Neutropenia
02/2014
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2008
1Neuroinflammatory Diseases
10/2008
1Neoplasm Metastasis (Metastasis)
10/2007
1Viremia
09/2007
1Brain Diseases (Brain Disorder)
06/2007
1Leukocytosis (Pleocytosis)
06/2007
1Hematologic Neoplasms (Hematological Malignancy)
06/2005
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2004
1Residual Neoplasm
01/2002
1Epstein-Barr Virus Infections
01/2002
1Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2001
1Metabolic Bone Diseases (Osteopenia)
03/2001
1Congenital Abnormalities (Deformity)
03/2001
1Inborn Genetic Diseases (Disease, Hereditary)
03/2001
1Osteogenesis Imperfecta (Lobstein Disease)
03/2001
1Ewing Sarcoma (Sarcoma, Ewing)
12/2000
1Rhabdomyosarcoma
12/2000
1Vesicular Stomatitis
02/2000

Drug/Important Bio-Agent (IBA)

10AntigensIBA
06/2013 - 12/2000
5Cancer VaccinesIBA
03/2010 - 12/2000
4Interleukin-2 (IL2)IBA
03/2010 - 12/2000
4Monoclonal AntibodiesIBA
01/2009 - 02/2000
4Proteins (Proteins, Gene)FDA Link
06/2007 - 02/2000
4CytokinesIBA
01/2002 - 07/2000
3Chimeric Antigen ReceptorsIBA
06/2013 - 10/2001
3Pharmaceutical PreparationsIBA
03/2010 - 08/2001
3CD40 Ligand (CD40L)IBA
03/2010 - 04/2001
3Antiviral Agents (Antivirals)IBA
09/2007 - 11/2005
3AntibodiesIBA
03/2006 - 12/2000
3Peptides (Polypeptides)IBA
12/2004 - 04/2001
2Interleukin-15 (Interleukin 15)IBA
06/2010 - 01/2003
2CD19 AntigensIBA
06/2010 - 10/2006
2Neoplasm Antigens (Tumor Antigens)IBA
01/2009 - 12/2000
2Interleukin-12 (IL 12)IBA
10/2007 - 01/2003
2Viral DNAIBA
09/2007 - 06/2007
2Alemtuzumab (Campath)FDA Link
06/2007 - 11/2005
2Cytostatic AgentsIBA
02/2005 - 08/2001
2ChemokinesIBA
01/2002 - 07/2000
1Anti-Bacterial Agents (Antibiotics)IBA
02/2014
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2014
1AndrogensIBA
06/2013
1Annexin A5IBA
06/2010
1VaccinesIBA
01/2009
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
03/2006
1PolylysineIBA
12/2004
1dl1520 (ONYX-015)IBA
04/2004
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2003
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2002
1Transforming Growth Factor beta (TGF-beta)IBA
01/2002
1EpitopesIBA
10/2001
1GangliosidesIBA
10/2001
1Complement System Proteins (Complement)IBA
08/2001
1Immunoglobulin Idiotypes (Idiotype, Immunoglobulin)IBA
05/2001
1Histocompatibility Antigens Class IIBA
04/2001
1Collagen Type I (Type I Collagen)IBA
03/2001
1Viral AntigensIBA
02/2001
1Single-Chain AntibodiesIBA
12/2000
1Rituximab (Mabthera)FDA Link
02/2000
1Glycoproteins (Glycoprotein)IBA
02/2000

Therapy/Procedure

15Therapeutics
06/2013 - 02/2000
6Stem Cell Transplantation
09/2007 - 02/2000
5Immunotherapy
06/2013 - 02/2001
3Transplantation
02/2014 - 02/2001
3Hematopoietic Stem Cell Transplantation
10/2008 - 03/2006
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2002 - 03/2001
1Length of Stay
02/2014
1Salvage Therapy
04/2010
1Drug Therapy (Chemotherapy)
04/2010
1Aftercare (After-Treatment)
10/2007
1Intravenous Administration
04/2004